Abstract:Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM), common incurable diseases caused by protein misfolding, have shown extensive correlation with each other via cross-aggregation between their related pathogenic peptide, amyloid beta protein (A beta) and human islet amyloid polypeptide (hIAPP), respectively. However, little is known about how these two peptides affect the cross-amyloid aggregation process in vivo. To better simulate the intracorporal environment, where different forms of amyloid aggregates co-exist and very few aggregates probably attach to the vessel wall as seeds, herein, we study the seeded-aggregation of A beta and hIAPP in the presence of homogeneous or heterogeneous seeds, both in solution and on the solid surface, with different monomer and seed concentrations. In this study, Thioflavin T (ThT) fluorescence assay, atomic force microscopy (AFM), and far-UV circular dichroism (CD) were performed to investigate the aggregation process in solution. Moreover, the binding of monomers with seeds on solid surface was detected by quartz crystal microbalance with dissipation (QCM-D). The 3-(4,5-dime-thylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays with human neuroblastoma cells (SH-SY5Y) were finally used to test the cytotoxicity caused by the aggregates. Series of analyses confirmed that a small amount of A beta 40 or hIAPP seeds (1/50 of the monomers in solution) significantly changed the aggregation pathway, forming heterogeneous aggregates with different morphologies and increased beta-sheet structures. MTT result showed that the heterogeneous aggregates obtained with A beta 40 and hIAPP seeding reduced the cell viability to 70.5% and 74.4%, respectively, both causing higher cytotoxicity than homogeneous aggregates (82.9% and 76.5%, respectively). The results in solution and on the solid surface both prove that A beta 40 and hIAPP seeds can not only induce rapid aggregation of their homogeneous monomers but also promote the heterogeneous monomers to aggregate, but monomer-heterogeneous seed binding efficiency is lower than that between homogeneous species. The differences in seeding and cross-seeding ability of A beta 40 and hIAPP indicate the barriers depended on the sequence similarity and structural compatibility between different amyloid aggregates. In the case of heterogeneous aggregation, aggregation features largely depend on the seeds. Furthermore, hIAPP seeds exhibited higher cross-seeding efficiency than A beta 40 seeds on the solid surface, which is different from the result in solution where A beta 40 seeds indicating the influence of interfacial properties on aggregation process. This finding would give a deep understanding of the cross-seeding aggregation process and we hope that this work will stimulate more research to explore all possible fundamental and practical aspects of amyloid cross-seeding.

Computational Investigation of Coaggregation and Cross-Seeding between Aβ and hIAPP Underpinning the Cross-Talk in Alzheimer's Disease and Type 2 Diabetes

Cross-Seeding Interaction Between Β-Amyloid and Human Islet Amyloid Polypeptide.

Molecular Understanding of Aβ-hIAPP Cross-Seeding Assemblies on Lipid Membranes

Experimental and Computational Protocols for Studies of Cross-Seeding Amyloid Assemblies.

Seed-Induced Heterogeneous Cross-Seeding Self-Assembly of Human and Rat Islet Polypeptides.

Polymorphic Cross-Seeding Amyloid Assemblies of Amyloid-Β and Human Islet Amyloid Polypeptide.

Mechanistic Insights into the Co-Aggregation of Aβ and hIAPP: An All-Atom Molecular Dynamic Study

Mechanistic Insights into the Polymorphic Associations and Cross-Seeding of Aβ and hIAPP in the Presence of Histidine Tautomerism: An All-Atom Molecular Dynamic Study

Identification of hybrid amyloid strains assembled from amyloid-β and human islet amyloid polypeptide

Islet amyloid polypeptide fibril catalyzes amyloid-β aggregation by promoting fibril nucleation rather than direct axial growth

Mechanistic Insights Into The Co-Aggregation Of A Beta And Hiapp: An All-Atom Molecular Dynamic Study

Seeding and Cross-Seeding Aggregations of A40 and hIAPP in Solution and on Surface

Seeding and Cross-Seeding Aggregations of A beta 40 and hIAPP in Solution and on Surface

Molecular interaction between type 2 diabetes and Alzheimer’s disease through cross-seeding of protein misfolding

Common fibrillar spines of amyloid-β and human islet amyloid polypeptide revealed by microelectron diffraction and structure-based inhibitors

Structural and energetic insight into the cross-seeding amyloid assemblies of human IAPP and rat IAPP

Computational insights into the cross-talk between medin and A β : implications for age-related vascular risk factors in Alzheimer's disease

Dissecting the Molecular Mechanisms of the Co-Aggregation of Aβ40 and Aβ42 Peptides: A REMD Simulation Study

Interaction of human IAPP and Aβ1-42 aggravated the AD-related pathology and impaired the cognition in mice

Computational Insights into the Cross-Talk Between Medin and Aβ: Implications for Age-Related Vascular Risk Factors in Alzheimer's Disease.

Interaction of human IAPP and A<sub>1-42</sub> aggravated the AD-related pathology and impaired the cognition in mice